Understand the source comparison
Peptides for Erectile Dysfunction: The Compound Comparison
PT-141 (Bremelanotide) MC4R agonist → central arousal FDA-approved (Vyleesi, female HSDD) Male ED trials: 33% improvement $29.99 Kisspeptin GnRH → LH/FSH → testosterone Not approved Neuroendocrine sexual arousal pathway $39.99 Melanotan II MC4R + MC1R → arousa
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- PT-141 (Bremelanotide)
- MC4R agonist → central arousal
- FDA-approved (Vyleesi, female HSDD)
- Male ED trials: 33% improvement
- $29.99
- Kisspeptin
- GnRH → LH/FSH → testosterone
- Not approved
- Neuroendocrine sexual arousal pathway
- $39.99
- Melanotan II
- MC4R + MC1R → arousal + tanning
- Documented pro-erectile effects